E2F3 and neuroblastoma: We postulate that 6p22.3 region becomes hypomethylated or that E2F3 can be a susceptibility gene influenced by polymorphisms, lying within putative regulatory region, resulting in augmented E2F3 expression associated with disease phenotype and NB 4S patient’s outcome.